Allianz Asset Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-81,104
Closed -$14M 2318
2020
Q4
$14M Sell
81,104
-27,421
-25% -$4.44M 0.01% 736
2020
Q3
$15.1M Buy
108,525
+14,812
+16% +$1.98M 0.02% 652
2020
Q2
$11.2M Buy
93,713
+57,033
+155% +$6.76M 0.01% 847
2020
Q1
$3.67M Sell
36,680
-9,814
-21% -$1.18M ﹤0.01% 1286
2019
Q4
$5.46M Sell
46,494
-1,817
-4% -$180K 0.01% 1447
2019
Q3
$4.15M Sell
48,311
-12,590
-21% -$953K ﹤0.01% 1533
2019
Q2
$3.95M Buy
60,901
+33,477
+122% +$2.08M ﹤0.01% 1605
2019
Q1
$1.71M Sell
27,424
-9,701
-26% -$456K ﹤0.01% 1893
2018
Q4
$1.44M Sell
37,125
-230,972
-86% -$10.3M ﹤0.01% 1887
2018
Q3
$15.3M Sell
268,097
-58,374
-18% -$3.65M 0.01% 1053
2018
Q2
$26.1M Buy
326,471
+50,097
+18% +$4.16M 0.03% 725
2018
Q1
$24M Buy
276,374
+14,813
+6% +$1.2M 0.02% 776
2017
Q4
$18.1M Buy
261,561
+186,753
+250% +$14.9M 0.01% 1031
2017
Q3
$6.8M Buy
74,808
+63,629
+569% +$5.45M 0.01% 1476
2017
Q2
$832K Sell
11,179
-858
-7% -$68.7K ﹤0.01% 2280
2017
Q1
$1.13M Buy
+12,037
New +$1.09M ﹤0.01% 2200
2016
Q4
Sell
-91,179
Closed -$9.52M 2690
2016
Q3
$9.52M Sell
91,179
-15,500
-15% -$1.4M 0.01% 1347
2016
Q2
$7.87M Buy
+106,679
New +$7.24M 0.01% 1331

Other funds holding NVRO

Allianz Asset Management's NVRO Position: Q1 2021 in Review

Allianz Asset Management sold out of NEVRO CORP. (NVRO) in Q1 2021, closing a stake of 81,104 shares — an estimated $14M sold.

Allianz Asset Management first reported a position in NVRO in Q2 2016 and held it in 18 quarters. The position peaked at $26.1M in Q2 2018. 204 funds tracked by Wall St. Rank hold NVRO as of Q1 2021.

  • Allianz Asset Management reported no remaining NEVRO CORP. position as of Q1 2021 after selling out during the quarter.
  • Allianz Asset Management sold 81,104 NEVRO CORP. shares in Q1 2021, an estimated $14M.
  • Allianz Asset Management first reported a position in NEVRO CORP. in Q2 2016 and held it in 18 quarters.
  • Allianz Asset Management's NEVRO CORP. position peaked at $26.1M in Q2 2018.
  • 204 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2021.

Based on Allianz Asset Management's 13F filing for Q1 2021, filed 13 May 2021.